Canaccord Adams adds Inverness Medical Innovations (NYSE AMEX: IMA) to its 'Best Ideas' list. Price target raised from $36 to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE